Harvard Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Harvard Bioscience

25/04/2023 14:32

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 6 cents​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of 5 cents per share.
    * Revenue rose 4.2% to $29.98 million from a year ago;
analysts
expected $28.85 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
1
cent​.
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harvard Bioscience Inc shares had risen by 16.7% this
quarter and gained 76.9% so far this year.
    * The company reported quarterly net income of $622
thousand.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 25 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.05           0.06           Beat
 Dec. 31 2022      0.03           0.04           Beat
 Sep. 30 2022      0.07           -0.01          Missed
 Jun. 30 2022      0.06           0.05           Missed